The safety and efficacy of a novel topical cosmeceutical compound combined with oral isotretinoin and laser treatments for active acne and acne scarring

Dermatol Ther. 2022 Jul;35(7):e15512. doi: 10.1111/dth.15512. Epub 2022 Apr 26.

Authors

Samina Nazarali¹, Alexis Pantaleon², Sojna Sajic², Dusan Sajic^{2

3

4}

Affiliations

¹ Department of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada.
² Derma Skin Institute, Guelph, Ontario, Canada.
³ Faculty of Health Sciences, McMaster University, Waterloo, Ontario, Canada.
⁴ Guelph Dermatology Research, Guelph, Ontario, Canada.

PMID: 35426188
DOI: 10.1111/dth.15512

No abstract available

Publication types

Letter

MeSH terms

Acne Vulgaris* / drug therapy
Administration, Oral
Cicatrix / therapy
Cosmeceuticals* / therapeutic use
Dermatologic Agents*
Humans
Isotretinoin
Lasers
Treatment Outcome

Substances

Cosmeceuticals
Dermatologic Agents
Isotretinoin